vs
英美资源集团（AMSC）与湘南美容医疗集团（SBC）财务数据对比。点击上方公司名可切换其他公司
英美资源集团的季度营收约是湘南美容医疗集团的1.9倍（$74.5M vs $39.6M），英美资源集团净利率更高（158.1% vs 35.9%，领先122.2%），英美资源集团同比增速更快（21.4% vs -10.9%），湘南美容医疗集团自由现金流更多（$51.2M vs $2.4M），过去两年英美资源集团的营收复合增速更高（33.2% vs -15.0%）
英美资源集团是一家总部位于英国伦敦的跨国矿业企业，是全球最大的铂金生产商，产量约占全球总产出的40%，同时也是钻石、铜、镍、铁矿石、多卤石、炼焦煤的主要供应商，业务布局覆盖非洲、亚洲、大洋洲、欧洲、南北美洲多个地区。
湘南美容医疗集团是总部位于日本的知名医疗服务提供商，核心业务覆盖美容整形、皮肤科诊疗、抗衰老健康护理等领域，在日本各地运营大量连锁诊所，同时服务本地居民及赴日就医的国际游客。
AMSC vs SBC — 直观对比
营收规模更大
AMSC
是对方的1.9倍
$39.6M
营收增速更快
AMSC
高出32.3%
-10.9%
净利率更高
AMSC
高出122.2%
35.9%
自由现金流更多
SBC
多$48.8M
$2.4M
两年增速更快
AMSC
近两年复合增速
-15.0%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $74.5M | $39.6M |
| 净利润 | $117.8M | $14.2M |
| 毛利率 | 30.7% | 73.1% |
| 营业利润率 | 4.5% | 32.5% |
| 净利率 | 158.1% | 35.9% |
| 营收同比 | 21.4% | -10.9% |
| 净利润同比 | 4679.1% | 117.2% |
| 每股收益（稀释后） | $2.62 | $0.15 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMSCSBC
| Q4 25 | $74.5M | $39.6M | ||
| Q3 25 | $65.9M | $43.4M | ||
| Q2 25 | $72.4M | $43.4M | ||
| Q1 25 | $66.7M | $47.3M | ||
| Q4 24 | $61.4M | $44.4M | ||
| Q3 24 | $54.5M | $53.1M | ||
| Q2 24 | $40.3M | $53.1M | ||
| Q1 24 | $42.0M | $54.8M |
净利润AMSCSBC
| Q4 25 | $117.8M | $14.2M | ||
| Q3 25 | $4.8M | $12.8M | ||
| Q2 25 | $6.7M | $2.5M | ||
| Q1 25 | $1.2M | $21.5M | ||
| Q4 24 | $2.5M | $6.5M | ||
| Q3 24 | $4.9M | $2.8M | ||
| Q2 24 | $-2.5M | $18.5M | ||
| Q1 24 | $-1.6M | $18.8M |
毛利率AMSCSBC
| Q4 25 | 30.7% | 73.1% | ||
| Q3 25 | 31.0% | 70.6% | ||
| Q2 25 | 33.8% | 69.2% | ||
| Q1 25 | 26.5% | 79.7% | ||
| Q4 24 | 26.6% | 76.3% | ||
| Q3 24 | 28.7% | 81.5% | ||
| Q2 24 | 30.3% | 74.2% | ||
| Q1 24 | 24.8% | 72.1% |
营业利润率AMSCSBC
| Q4 25 | 4.5% | 32.5% | ||
| Q3 25 | 4.5% | 36.6% | ||
| Q2 25 | 7.8% | 33.6% | ||
| Q1 25 | 2.5% | 51.1% | ||
| Q4 24 | 2.1% | 10.6% | ||
| Q3 24 | -1.4% | 26.1% | ||
| Q2 24 | -8.2% | 51.4% | ||
| Q1 24 | -5.3% | 44.6% |
净利率AMSCSBC
| Q4 25 | 158.1% | 35.9% | ||
| Q3 25 | 7.2% | 29.6% | ||
| Q2 25 | 9.3% | 5.7% | ||
| Q1 25 | 1.8% | 45.4% | ||
| Q4 24 | 4.0% | 14.7% | ||
| Q3 24 | 9.0% | 5.3% | ||
| Q2 24 | -6.3% | 34.8% | ||
| Q1 24 | -3.8% | 34.2% |
每股收益（稀释后）AMSCSBC
| Q4 25 | $2.62 | $0.15 | ||
| Q3 25 | $0.11 | $0.12 | ||
| Q2 25 | $0.17 | $0.02 | ||
| Q1 25 | $0.04 | $0.21 | ||
| Q4 24 | $0.06 | $0.05 | ||
| Q3 24 | $0.13 | $0.03 | ||
| Q2 24 | $-0.07 | $0.20 | ||
| Q1 24 | $-0.03 | $0.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $141.1M | $164.1M |
| 总债务越低越好 | — | $42.8M |
| 股东权益账面价值 | $536.8M | $248.3M |
| 总资产 | $719.5M | $380.4M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资AMSCSBC
| Q4 25 | $141.1M | $164.1M | ||
| Q3 25 | $212.9M | $127.4M | ||
| Q2 25 | $207.9M | $152.7M | ||
| Q1 25 | $79.5M | $132.1M | ||
| Q4 24 | $75.2M | $125.0M | ||
| Q3 24 | $72.1M | $137.4M | ||
| Q2 24 | $93.5M | — | ||
| Q1 24 | $90.5M | — |
总债务AMSCSBC
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益AMSCSBC
| Q4 25 | $536.8M | $248.3M | ||
| Q3 25 | $342.2M | $248.0M | ||
| Q2 25 | $333.1M | $244.6M | ||
| Q1 25 | $197.1M | $226.4M | ||
| Q4 24 | $192.7M | $195.1M | ||
| Q3 24 | $187.0M | $205.0M | ||
| Q2 24 | $143.3M | $8.8M | ||
| Q1 24 | $144.6M | $9.0M |
总资产AMSCSBC
| Q4 25 | $719.5M | $380.4M | ||
| Q3 25 | $445.6M | $321.4M | ||
| Q2 25 | $452.8M | $315.3M | ||
| Q1 25 | $310.5M | $284.6M | ||
| Q4 24 | $310.3M | $266.1M | ||
| Q3 24 | $298.4M | $296.5M | ||
| Q2 24 | $240.1M | $19.5M | ||
| Q1 24 | $232.8M | $19.8M |
负债/权益比AMSCSBC
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.2M | $52.0M |
| 自由现金流经营现金流 - 资本支出 | $2.4M | $51.2M |
| 自由现金流率自由现金流/营收 | 3.2% | 129.3% |
| 资本支出强度资本支出/营收 | 1.2% | 2.0% |
| 现金转化率经营现金流/净利润 | 0.03× | 3.66× |
| 过去12个月自由现金流最近4个季度 | $16.0M | $23.3M |
8季度趋势，按日历期对齐
经营现金流AMSCSBC
| Q4 25 | $3.2M | $52.0M | ||
| Q3 25 | $6.5M | $-20.9M | ||
| Q2 25 | $4.1M | $-8.3M | ||
| Q1 25 | $6.3M | $1.9M | ||
| Q4 24 | $5.9M | $-7.3M | ||
| Q3 24 | $12.7M | $5.0M | ||
| Q2 24 | $3.4M | $19.2M | ||
| Q1 24 | $2.2M | $3.7M |
自由现金流AMSCSBC
| Q4 25 | $2.4M | $51.2M | ||
| Q3 25 | $5.1M | $-20.9M | ||
| Q2 25 | $3.3M | $-8.6M | ||
| Q1 25 | $5.3M | $1.7M | ||
| Q4 24 | $5.3M | $-7.9M | ||
| Q3 24 | $12.1M | $4.6M | ||
| Q2 24 | $3.1M | $18.3M | ||
| Q1 24 | $1.9M | $3.0M |
自由现金流率AMSCSBC
| Q4 25 | 3.2% | 129.3% | ||
| Q3 25 | 7.7% | -48.3% | ||
| Q2 25 | 4.6% | -19.9% | ||
| Q1 25 | 7.9% | 3.5% | ||
| Q4 24 | 8.7% | -17.8% | ||
| Q3 24 | 22.3% | 8.7% | ||
| Q2 24 | 7.8% | 34.5% | ||
| Q1 24 | 4.6% | 5.4% |
资本支出强度AMSCSBC
| Q4 25 | 1.2% | 2.0% | ||
| Q3 25 | 2.1% | 0.1% | ||
| Q2 25 | 1.1% | 0.7% | ||
| Q1 25 | 1.6% | 0.5% | ||
| Q4 24 | 0.9% | 1.3% | ||
| Q3 24 | 1.1% | 0.8% | ||
| Q2 24 | 0.7% | 1.6% | ||
| Q1 24 | 0.7% | 1.3% |
现金转化率AMSCSBC
| Q4 25 | 0.03× | 3.66× | ||
| Q3 25 | 1.37× | -1.63× | ||
| Q2 25 | 0.61× | -3.39× | ||
| Q1 25 | 5.22× | 0.09× | ||
| Q4 24 | 2.38× | -1.12× | ||
| Q3 24 | 2.60× | 1.77× | ||
| Q2 24 | — | 1.04× | ||
| Q1 24 | — | 0.20× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMSC
| Equipment And Systems | $56.0M | 75% |
| Megatran | $14.1M | 19% |
| Comtrafo Industria De Transformadores Eletricos SA | $4.6M | 6% |
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
